Medical News

RSS

Disabling RGS14 gene helps mice remember better

Deleting a certain gene in mice can make them smarter by unlocking a mysterious region of the brain considered to be relatively inflexible, scientists at Emory University School of Medicine have found.

18 Sep 2010

Emergent BioSolutions signs contract with HHS to develop rPA anthrax vaccine

Emergent BioSolutions Inc. announced today that it has signed a contract, valued at up to $186.6 million, with the Biomedical Advanced Research and Development Authority of the Department of Health and Human Services, for the development of a recombinant protective antigen anthrax vaccine.

18 Sep 2010

Emisphere’s SNAC drug successful in reducing food intake; increasing satiety

Emisphere Technologies, Inc. today announced that a clinical study found that the company's proprietary oral SNAC (Sodium N-[8-(2-hydroxybenzoyl) Amino] Caprylate ("SNAC") additive, in combination with two digestive hormones, was successful in reducing food intake and increasing satiety in healthy male subjects.

18 Sep 2010

CBO finds generic drugs save Medicare $33 billion in 2007

A new government report finds that the use of generic medications saved the Medicare program and its beneficiaries about $33 billion in 2007, The Associated Press/BusinessWeek report. The Congressional Budget Office report "says an additional $14 billion is expected as first-time generics enter the market through 2012. Medicare Part D is Medicare's prescription drug program" (9/15).

18 Sep 2010

Health premiums rise as states consider how they'll implement reforms

Overall health insurance premiums rose 7 percent in 2009, even as the number of people with health coverage fell. "Individual premium revenues rose 15 percent while group premiums, which involve mostly employers, rose nearly 3 percent, according to the report from the National Association of Insurance Commissioners, an organization whose prominence has grown following passage of the new U.S. health reform law."

18 Sep 2010

Minocycline plus N-acetylcysteine may help treat TBI

Traumatic brain injury (TBI) is a serious public health problem in the United States. Recent data show that approximately 1.7 million people sustain a traumatic brain injury annually. While the majority of TBIs are concussions or other mild forms, traumatic brain injuries contribute to a substantial number of deaths and cases of permanent disability.

18 Sep 2010

Use of oral medications for diabetes increases among Americans: Report

The proportion of Americans reporting treatment for diabetes who took oral medications to treat their condition increased from 60 percent in 1997 to 77 percent in 2007, a 28 percent increase according to the latest News and Numbers from the Agency for Healthcare Research and Quality. During the same period, the proportion taking insulin to control their diabetes fell from 38 percent to 24 percent.

18 Sep 2010

Researchers identify new target for cystic fibrosis

The lab of Kevin Foskett, PhD, the Isaac Ott Professor of Physiology at the University of Pennsylvania School of Medicine, has found a possible new target for fighting cystic fibrosis (CF) that could compensate for the lack of a functioning ion channel in affected CF-related cells. Their finding appears in the Journal of Clinical Investigation.

18 Sep 2010

Research Roundup: Assessing physician quality; Community health centers' future; Why doctors take gifts; Access to HIV treatment

Archives of Internal Medicine: Associations Between Physician Characteristics And Quality Of Care - Since "most patients do not have access to physician quality measures," they are often encouraged to use public information such as malpractice claims and board certification status to chose a doctor, according to this report that used 2004-2005 insurance claims from about 10,000 Massachusetts physicians for more than 1.13 million adults.

18 Sep 2010

FDA accepts to review Aricept NDA for Alzheimer's disease

Teikoku Pharma USA, Inc., an international specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for a new weekly transdermal patch of Aricept, a leading medication for the treatment of Alzheimer's disease.

18 Sep 2010

FDA reviews Actos drug for bladder cancer risk

The U.S. Food and Drug Administration today announced it has begun a safety review of the diabetes drug Actos (pioglitazone), after receiving preliminary results from a long-term observational study designed to evaluate the risk of bladder cancer associated with use of this drug.

18 Sep 2010

Elixir Medical commences enrollment in EXCELLA BD trial for DESyne BD Novolimus Eluting CSS

Elixir Medical Corporation, a developer of product platforms that combine innovative medical devices with potent pharmaceuticals for site-specific therapies, announced the initiation of patient enrollment in the EXCELLA BD Randomized Clinical Trial designed to evaluate Elixir's next generation Novolimus Eluting Coronary Stent System (CSS) with bioabsorbable coating, the Elixir DESyne BD Novolimus Eluting CSS.

18 Sep 2010

Researchers discover evolutionary nature of bacteria to spread chronic infectious disease

Researchers from the Center for Genomic Sciences at Allegheny General Hospital (AGH) in Pittsburgh have made a landmark discovery about the evolutionary nature of bacteria in the setting of chronic infectious disease. Reporting today in the journal PLos Pathogens, the AGH team documents for the first time that bacteria engage in a process called horizontal gene transfer to evolve rapidly during the course of a single infection.

18 Sep 2010

BARDA awards contract to Emergent BioSolutions for anthrax vaccine development

The U.S. Department of Health and Human Services' Biomedical Advanced Research and Development Authority (BARDA) awarded a $51 million contract to Emergent BioSolutions, Inc., of Rockville, Md., for the development of a new anthrax vaccine using the protective antigen (rPA) to stimulate a protective immune response that neutralizes the anthrax toxins.

18 Sep 2010

Boehringer Ingelheim commences afatinib Phase III clinical trial in advanced breast cancer

Boehringer Ingelheim today announced the initiation of a phase III clinical trial to investigate one of its most advanced oncology pipeline compounds, afatinib, for the treatment of patients with advanced (metastatic) breast cancer. Afatinib is an oral compound (taken as a tablet), which is a next generation, targeted therapy, that irreversibly inhibits both, the epidermal growth factor receptor (EGFR/HER1) and the human epidermal receptor HER2, which are involved in tumour growth and spread.

18 Sep 2010

FDA decides to review information on Avastin for advanced HER2-negative breast cancer

Genentech, Inc., a member of the Roche Group, today announced that information submitted by the company to the U.S. Food and Drug Administration (FDA) during the review of the supplemental Biologics License Applications (sBLAs) for Avastin (bevacizumab) for previously untreated (first-line) advanced HER2-negative breast cancer has been deemed a major amendment.

18 Sep 2010

Accuray Incorporated showcases CyberKnife VSI System at ESTRO Annual Congress

Accuray Incorporated, a global leader in the field of radiosurgery, announced today that for the first time in Europe the company showcased its latest offering, the CyberKnife VSI System, at ESTRO 29, the Annual Congress of the European Society for Therapeutic Radiology and Oncology in Barcelona, Spain.

18 Sep 2010

Today's Opinions: Recession's impact on the uninsured; Repeal of health reform? Then what?

The record number of people last year without health insurance — 50.7 million, up from 46.3 million in 2008 — provides stark evidence of why the country desperately needs the health care reforms enacted in March (9/16).

18 Sep 2010

Solatube discusses green lighting at FMA Congress

Imagine a building in which sunlight could be captured and utilized in the most unexpected and never-before-seen places. Imagine the "World's First Green Olympics." Imagine employees who are happier, more productive, healthier and less prone to accidents. All are reality, thanks to Solatube International's tubular Daylighting Devices, which use state-of-the-art design to provide superior performance and efficiency to every daylighting application imaginable.

17 Sep 2010

Conference to discuss frontline of immunological research, its clinical application

The immune system is evolved to protect our body against a variety of infectious agents which can cause serious and often fatal diseases. We now appreciate that the immune system is also involved in surveillance of malignant transformation of normal cells that constitute our body, as well as rejection of transplanted organs.

17 Sep 2010

Medical News

Disabling RGS14 gene helps mice remember better

Emergent BioSolutions signs contract with HHS to develop rPA anthrax vaccine

Emisphere’s SNAC drug successful in reducing food intake; increasing satiety

CBO finds generic drugs save Medicare $33 billion in 2007

Health premiums rise as states consider how they'll implement reforms

Minocycline plus N-acetylcysteine may help treat TBI

Use of oral medications for diabetes increases among Americans: Report

Researchers identify new target for cystic fibrosis

Research Roundup: Assessing physician quality; Community health centers' future; Why doctors take gifts; Access to HIV treatment

FDA accepts to review Aricept NDA for Alzheimer's disease

FDA reviews Actos drug for bladder cancer risk

Elixir Medical commences enrollment in EXCELLA BD trial for DESyne BD Novolimus Eluting CSS

Researchers discover evolutionary nature of bacteria to spread chronic infectious disease

BARDA awards contract to Emergent BioSolutions for anthrax vaccine development

Boehringer Ingelheim commences afatinib Phase III clinical trial in advanced breast cancer

FDA decides to review information on Avastin for advanced HER2-negative breast cancer

Accuray Incorporated showcases CyberKnife VSI System at ESTRO Annual Congress

Today's Opinions: Recession's impact on the uninsured; Repeal of health reform? Then what?

Solatube discusses green lighting at FMA Congress

Conference to discuss frontline of immunological research, its clinical application

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News